IMATINIB MESYLATE 100 MG TAB

imatinib mesylate
$0.4912per EA
Low Outlier

Strength

100 mg/1

NDC

72485020290

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

7/17/2024

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208302

On Market Since

3/15/2019

Pharmacological Classes

Kinase Inhibitor
Protein Kinase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-19.3%

5Y

-84.3%

All

-90.1%